The Inspire Sleep Apnea Implant is a medical device that is implanted in to the body for the treating snoring and obstructive sleep apnea (OSA) syndrome.
Obstructive Sleep Apnea Syndrome
Obstructive sleep apnea syndrome is a disease due to relapsing episodes of sleep apnea. This is usually a condition where breathing stops for a lot more than 10 seconds, during which oxygen saturation in the blood is reduced by a lot more than 4%.
OSA syndrome occurs during sleep, when the muscles of upper airways relax, evoking the obstruction of the respiratory system. This results in deterioration of blood oxygenation and provokes short unconscious wake-up episodes through the entire night. An unhealthy pattern of sleep places stress on the body, causing increased blood pressure and development of severe diseases. The diseases caused by OSA can be physical, such as hypertension, myocardium infarction and stroke. They could also be mental, including depression, chronic fatigue syndrome, lack of memory and concentration.
Before any treatment, a sleep study or perhaps a polysomnography is needed. The polysomnography calculates the apnea index, that is the frequency of apnea episodes during one hour of sleep and determines the severity of the disease. The apnea index is known as significant if there are a lot more than 20 apnea episodes each hour, whatever the presence or lack of clinical symptoms.
ufa The gold standard of treatment for OSA syndrome is CPAP-therapy. However, CPAP therapy is not for everyone as many folks think it is uncomfortable to sleep with the mask on the face and the device itself could be loud, especially as it commonly sits near the head. Only 25% of patients may use CPAP-therapy for an extended period of time.
Therefore, recently Inspire Medical Systems Inc. has come up with a very effective solution with the Inspire ANTI SNORING Implant.
How The Inspire ANTI SNORING Implant Works
The Inspire ANTI SNORING Implant is a battery operated device that promotes electrostimulation of the sublingual nerve. The battery life is approximately a decade.
The main unit of the device is placed beneath the skin, on the front right side of the chest also it monitors the phase of breathing. Another electrode is implanted for stimulation of the sublingual nerve, which creates muscle tension. This opens the upper airways and allows the tongue to stick out, and helps maintain the airways open while asleep.
As well as the two electrodes, this product also includes a handy small remote switch, which actually turns on the device before sleep and switches it off once awake. This disables the electrodes from disturbing the processes of communication and eating through the active phase of the day, when a person needs physiological narrowing of the larynx and tongue movements for these procedures.
The patient may feel light involuntary contractions of the larynx, or tongue movements during initial usage of these devices. These movements do not cause pain, instead just a minor discomfort. These unpleasant effects disappear following the first few uses of these devices.
Generally, the implant ought to be checked one or two 2 times per year. However, with regards to the situation, an Inspire therapy-trained doctor may consult patients more or less often.
The Inspire ANTI SNORING Implant is only suitable for:
Patients who are more than 22 years old.
Patients who’ve been identified as having moderate or severe obstructive sleep apnea syndrome.
Patients with an apnea index in the number of 20 to 65.
Patients who are uncomfortable with using CPAP therapy or did not work.
Patients with a body mass index of less than 32.
Body mass index (BMI) = weight (kg) / height^2 (m2).
An individual with a weight of 80 kg and a height of 170 cm has
BMI = 80kg / (1.7m ^ 2) = 80 / 2.89 = 27.68 kg/ m2
The Inspire ANTI SNORING Implant may potentially replace CPAP therapy as ‘the gold standard’ of treatment for obstructive sleep apnea syndrome. A report by Dr. Ryan J. et al. has shown that after implantation of the Inspire ANTI SNORING Implant, snoring is greatly decreased. A percentage of “no” or “soft” snoring changed from 22% at start of the treatment to 88% at 12 months and 91% at two years after the treatment. Also, the apnea index was reduced from 31 to 14. 82% of the patients in the study reported a nightly usage of this therapy for five years. Therefore, it really is evident that method is highly effective and easy to use!